Literature DB >> 12210852

Genetics of parkinsonism.

Katrina Gwinn-Hardy1.   

Abstract

Parkinson's disease (PD) was noted to have a familial component as early as 1880 (Leroux, 1880). More recently, the discovery of several genetic factors influencing parkinsonism has emphasized the importance of heredity in PD. The clinical spectrum of familial parkinsonism is wide; it includes not only PD, but also dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), essential tremor, and other disorders. In the general population, it is likely that PD results from combined genetic and environmental factors, most of which are not yet known. The discovery of causal mutations in the gene for alpha-synuclein, parkin, and of genetic linkages to chromosomes 2p4, 4p5, and three loci on 1q6-8 have revolutionized PD research. This review focuses on recent progress in the Mendelian genetics of PD and those diseases in which parkinsonism is a prominent feature, and considers how these discoveries modify our beliefs regarding the etiology and pathogenesis of these disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210852     DOI: 10.1002/mds.10173

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

1.  Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features.

Authors:  Melissa Hanson; Melissa Honour; Amanda Singleton; Anthony Crawley; Andrew Singleton; John Hardy; Katrina Gwinn-Hardy
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 2.  Inflammation as a causative factor in the aetiology of Parkinson's disease.

Authors:  P S Whitton
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

3.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

4.  Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease.

Authors:  Shira G Ziegler; Michael J Eblan; Usha Gutti; Kathleen S Hruska; Barbara K Stubblefield; Ozlem Goker-Alpan; Mary E LaMarca; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2007-04-25       Impact factor: 4.797

5.  Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease.

Authors:  Yih-Ru Wu; Cheng-Kuang Wang; Chiung-Mei Chen; Yuying Hsu; Sih-Jing Lin; Yi-Ying Lin; Hon-Chung Fung; Kuo-Hsuan Chang; Guey-Jen Lee-Chen
Journal:  Hum Genet       Date:  2003-11-06       Impact factor: 4.132

Review 6.  The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects.

Authors:  Byron C Jones; Xuemei Huang; Richard B Mailman; Lu Lu; Robert W Williams
Journal:  J Biochem Mol Toxicol       Date:  2014-03-05       Impact factor: 3.642

7.  Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.

Authors:  Baek-Soo Han; Lorraine Iacovitti; Taku Katano; Nobutaka Hattori; Wongi Seol; Kwang-Soo Kim
Journal:  Neurosci Lett       Date:  2008-07-10       Impact factor: 3.046

8.  Angiotensin II protects against alpha-synuclein toxicity and reduces protein aggregation in vitro.

Authors:  Tom N Grammatopoulos; Tiago F Outeiro; Bradley T Hyman; David G Standaert
Journal:  Biochem Biophys Res Commun       Date:  2007-09-21       Impact factor: 3.575

9.  Significant linkage of Parkinson disease to chromosome 2q36-37.

Authors:  Nathan Pankratz; William C Nichols; Sean K Uniacke; Cheryl Halter; Alice Rudolph; Cliff Shults; P Michael Conneally; Tatiana Foroud
Journal:  Am J Hum Genet       Date:  2003-03-13       Impact factor: 11.025

10.  Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery.

Authors:  Margaret A Keller; Katrina Gwinn; Josefina Nash; Jonathan Horsford; Ran Zhang; Stephen S Rich; Roderick A Corriveau
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.